GLP-1 receptor agonists reduce appetite, make digestion happen more gradually and support steady calorie reduction
However, common side effects of GLP-1 medications are temporary, but they may persist in some patients
Glucagon-Like Peptide-1 Receptor AgonistAssociated Adverse Events Gastrointestinal Adverse Events Gastrointestinal adverse effects, most notably nausea, vomiting, diarrhoea, and constipation, are the most frequently reported safety events associated with GLP-1 receptor agonists and represent a leading cause of treatment discontinuation in clinical trials of obesity and type 2 diabetes
In turn, fasting may help support the weight loss achieved with semaglutide by using stored fat more quickly
Through Weight Loss Clinics and Specialists Medical weight loss clinics and obesity medicine specialists focus specifically on helping patients lose weight through medical interventions